According to BiondVax's latest financial reports the company's current EPS (TTM) is -$3.84. In 2022 the company made an earnings per share (EPS) of -$4.00 a decrease over its 2021 EPS that were of -$2.58.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.84 | -3.99% |
2022 | -$4.00 | 55.21% |
2021 | -$2.58 | 565.7% |
2020 | -$0.39 | -96.49% |
2019 | -$11.02 | 14.81% |
2018 | -$9.60 | 68.76% |
2017 | -$5.69 | 196.9% |
2016 | -$1.92 | -27.16% |
2015 | -$2.63 | 67.72% |
2014 | -$1.57 | -22.91% |
2013 | -$2.03 | -0.89% |
2012 | -$2.05 | 25.83% |
2011 | -$1.63 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -43.24% | ๐บ๐ธ USA |